Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.34101 | 13 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.12647 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.12491 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.07066 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.06826 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.21269 | 7 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.16629 | 7 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.10756 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.09172 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.12452 | 6 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.11638 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.09633 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.12623 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.11966 | 6 |